Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biomerica Inc (BMRA)

Biomerica Inc (BMRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 84,269
  • Shares Outstanding, K 11,753
  • Annual Sales, $ 6,690 K
  • Annual Income, $ -2,340 K
  • 60-Month Beta -0.90
  • Price/Sales 12.34
  • Price/Cash Flow N/A
  • Price/Book 4.90
Trade BMRA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +1,998,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.50 +26.00%
on 09/04/20
7.74 -10.47%
on 09/18/20
-0.44 (-5.97%)
since 08/28/20
3-Month
5.50 +26.00%
on 09/04/20
12.75 -45.65%
on 07/21/20
-0.32 (-4.41%)
since 06/30/20
52-Week
2.05 +238.05%
on 03/17/20
23.39 -70.37%
on 03/19/20
+3.68 (+113.23%)
since 09/30/19

Most Recent Stories

More News
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results

-- Fiscal fourth quarter revenues increase 133.7% over the prior year

BMRA : 6.93 (-3.35%)
Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors

Biomerica Inc. (NASDAQ: BMRA) today announced today the retirement of Janet Moore, the Company's Chief Financial Officer. After many years of dedicated service, Ms. Moore has decided to retire and pursue...

BMRA : 6.93 (-3.35%)
Company News for Aug 13, 2020

Companies in the news are: TCEHY, BOXL, BMRA, AMTX

TCEHY : 67.6500 (+3.20%)
BMRA : 6.93 (-3.35%)
AMTX : 3.20 (+0.95%)
BOXL : 1.6100 (-0.62%)
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests

Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for Biomerica's second U.S. patent pertaining to the Company's InFoods(R)...

BMRA : 6.93 (-3.35%)
LD Micro Announces Preliminary List of Presenters for the LD 500

LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACER : 2.88 (-7.99%)
ACU : 23.03 (+0.78%)
AEY : 1.9200 (+1.59%)
ADIL : 2.23 (-26.40%)
ADXS : 0.4100 (-2.61%)
AEHR : 1.3900 (-0.71%)
AIM : 2.15 (+1.42%)
AIRI : 1.2200 (-3.17%)
KERN : 3.64 (-2.15%)
ALIM : 4.86 (-6.18%)
ALLT : 9.10 (-1.62%)
AMS : 1.8100 (-7.65%)
ANVS : 4.81 (+0.84%)
APEN : 1.6900 (+1.20%)
APM : 2.68 (-43.70%)
AQB : 4.48 (-1.54%)
ARTL : 0.9926 (+11.53%)
ARHH : 0.8980 (+4.77%)
ATOM : 10.45 (-0.95%)
ATOS : 2.42 (-3.97%)
ACU.VN : 0.145 (+3.57%)
AUTO : 3.14 (-1.57%)
AYRO : 2.96 (-6.62%)
AYTU : 1.1900 (-0.83%)
AZRX : 0.7110 (-1.77%)
BLDP : 15.10 (unch)
BELFA : 11.71 (+4.30%)
BCDA : 2.27 (-2.16%)
BIOC : 4.41 (-2.65%)
BMRA : 6.93 (-3.35%)
BSGM : 4.93 (+1.02%)
BLNK : 10.31 (+3.20%)
BKEP : 1.5400 (-3.14%)
CLBS : 1.8000 (-4.26%)
CLXT : 5.49 (-4.69%)
ASUR : 7.55 (+0.80%)
BLGO : 0.1502 (-3.03%)
Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

EQNX::TICKER_START (NASDAQ:BMRA), EQNX::TICKER_END

BMRA : 6.93 (-3.35%)
Mayo Clinic joins Biomerica's InFoods(R) Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial

-- Biomerica also announces its first Japanese patent has been granted for its InFoods IBS Diagnostic Guided Therapy technology

BMRA : 6.93 (-3.35%)
Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution

EQNX::TICKER_START (NASDAQ:BMRA), EQNX::TICKER_END

BMRA : 6.93 (-3.35%)
Biomerica Announces Third Quarter Financial Results

Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $3,967,712 for the nine months ending February 29, 2020, compared to $4,034,822 for the period ended February 28, 2019. Sales for the three months...

BMRA : 6.93 (-3.35%)
Company News for Apr 3, 2020

Companies In The News Are: NEPT, BMRA, LK, WBA

BMRA : 6.93 (-3.35%)
WBA : 35.92 (+1.53%)
NEPT : 2.11 (-1.86%)
LK : 1.3800 (-54.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include...

See More

Key Turning Points

2nd Resistance Point 7.24
1st Resistance Point 7.08
Last Price 6.93
1st Support Level 6.85
2nd Support Level 6.78

See More

52-Week High 23.39
Fibonacci 61.8% 15.24
Fibonacci 50% 12.72
Fibonacci 38.2% 10.20
Last Price 6.93
52-Week Low 2.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar